Article
AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings
14 Nov 2024
Abstract excerpt
Glioblastoma is an aggressive brain cancer with a poor prognosis. The O6-methylguanine-DNA methyltransferase (MGMT) gene methylation status is crucial for treatment stratification, yet economic constraints often limit access. This study aims to develop an artificial intelligence (AI) framework for predicting MGMT methylation. Diagnostic magnetic resonance (MR) images in public repositories were used for training....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
